Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study

Lisa A. Beck, Diamant Tha├ži, Mette Deleuran, Marjolein de Bruin-Weller, Zhen Chen, Faisal A. Khokhar, Meng Zhang, Zafer E. Ozturk, Brad Shumel*

*Corresponding author for this work

    Fingerprint

    Dive into the research topics of 'Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study'. Together they form a unique fingerprint.

    Medicine & Life Sciences